Sivesh K Kamarajah
@Sivesh93
Followers
5K
Following
17K
Media
710
Statuses
9K
@NIHRcommunity Doctoral Fellow @UoB_IAHR @NIHR_GSU ๐. General Surgery SpR. Collaborations ๐ค @gecko_study | @STARSurgUK ๐ฒ๐พโก๏ธ๐ฌ๐ง
Birmingham, England
Joined August 2012
Extremely delighted to be awarded @NIHRcommunity Doctoral Fellowship for PhD Grateful for support from a strong team of supervisors Prof Morton, @aneelbhangu @pinkney_t @Nirantharakumar @shals_ahuja Really excited for the next 3 years! @NIHRresearch @NIHR_GSU @UoB_IAHR
๐ฅA good news message for surgical research๐ฅ @Sivesh93 is a general surgery ACF/ST3 who has won a highly prestigious, nationally competitive @NIHRcommunity Doctoral Fellowship, funding a 3-year PhD from Oct 2023 @UoB_IAHR. Here's what it all means๐งต:
21
6
107
Tolerability, toxicity, and outcomes following surgical and non-surgical approaches to the management of patients with locally advanced oesophageal squamous cell carcinoma: multicentre retrospective cohort study โก๏ธ https://t.co/vMrN5eMiOL This multicentre cohort study analysed
0
5
8
A new study has revealed overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications linked to their obesity, although more trials are needed to assess feasibility. ๐ https://t.co/Cep0luJwho
0
3
6
Take home, Matterhorn is the tip of the iceberg in what is coming in UGI. As surgeons we really have to actively engage and understand the biology of OG cancer, and plan our surgical treatment including oligometastatic disease (2/2).
0
2
7
we're growing, and this is a great chance to bring your thought-leadership, reviews, or data into the robotic surgery debate/expansion. Headed for Pubmed (with backlisting) late 2025 and free to publish until end of year.
๐ข Call for papers ๐๐บ๐ฝ๐ฎ๐ฐ๐ ๐ฆ๐๐ฟ๐ด๐ฒ๐ฟ๐ is seeking original, unpublished research papers in surgery and perioperative care, with a special focus on ๐ฟ๐ผ๐ฏ๐ผ๐๐ถ๐ฐ ๐๐๐ฟ๐ด๐ฒ๐ฟ๐. Open to authors worldwide. Learn more and submit your paper today: https://t.co/nbiBFdtTdD
0
5
14
I regularly stress test decisions, especially in (1) this era of financial cliffs, (2) a period of great global uncertainty, and also (3) when making decisions with patients. If you think that, and 49 others lessons might be useful, please consider reading this: 50 Lessons from
0
2
7
๐ฟPassionate about sustainable healthcare? ๐ฅผCurious about making surgery greener without compromising patient care? ๐Then join us at UoB for the 2025 Green Surgery Conference! ๐
Wednesday 17th December 2025 ๐Register: https://t.co/Nyke7zJVyv ๐Website: https://t.co/iVge2rzin8
0
8
9
We are deeply saddened by the passing of Prof Neil Smart. A giant in our field, Neil was a gifted surgeon, academic, & mentor whose impact on colorectal surgery was profound & far-reaching. Our thoughts are with his family, friends & all who knew him โก๏ธ https://t.co/RoUMD58lo5
2
33
136
# *SurgPASS Focus Group* : Engaging session on *acceptability and feasibility* of an innovative checklist " *SurgPASS* " to reduce post-emergency laparotomy mortality. Thanks to CHUDOP Emergency Teams @aneelbhangu @lawaniismail @NIHR_GSU @Sivesh93
0
4
4
Privileged to present Prof @Neil_J_Smart with the Geoff Oates medal today on behalf of @ACPGBI - our highest honour for contributions to coloproctology. Neil is a husband, father, friend, surgeon, academic, Editor in Chief @ColorectalDis & mentor to many-posted at Neilโs request
46
72
354
It's a pleasure to award @Neil_J_Smart a rare @NIHR_GSU Global Surgery Unit recognition medal. His influence is well well beyond the UK, and he has a career with a huge global impact. Forgive me for doing it digitally tonight (I have one of these rare beasts at home and the
5
23
84
๐ฆ๐๐ฟ๐ด๐ถ๐ฐ๐ฎ๐น ๐๐ถ๐๐ฒ ๐ถ๐ป๐ณ๐ฒ๐ฐ๐๐ถ๐ผ๐ป๐ ๐ฎ๐ฟ๐ฒ ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ฎ๐ฏ๐น๐ฒ. But post-trial uptake of ChEETAhโs proven intervention? Just 27%. A new study in Impact Surgery presents a logic model to guide scale-up. Read more: https://t.co/16nfk7t9pH
#GlobalSurgery
0
7
14
A study published in @eClinicalMed and led by UoB's Sivesh Kamarajah has highlighted considerable gaps in clinical practice guidelines for patients with acute pancreatitis, with a call to action for research to improve long-term outcomes in the future. https://t.co/jDUQY7d5cl
0
3
5
Thanks @asgbi for giving me the opportunity to share my experiences in #Gaza. Too many medical and academic institutions have been silent about what is going on - you should be congratulated. Our Royal Colleges and other Surgical / Medical Associations need to follow @asgbi
Wow what a Trauma session with โฆ@maynard_nickโฉ โฆ@Ammar_Darwish1โฉ hosted by โฆ@KateHancornโฉ #ASGBI2025
1
29
87
This first article in a seven part series presents an overview of the essential elements of the GRADE approach that has proved useful in systematic reviews, health technology assessment reports, and clinical practice guidelines https://t.co/rzV7gJl35l
0
61
147
This is a really important document. I was happy to be selected as a specialist committee member and I strongly feel that there is a clear direction for introducing RAS however the gaps in clinical efficacy and cost effectiveness cannot be ignored.
0
2
8
๐ขREGISTRATION NOW LIVE! Register at: https://t.co/JIpLBeJ2th Join us in Geneva for the launch of the Lancet Health Policy article on Global Surgery 2025-2035! We will be hosting a side event at the 2025 World Health Assembly!๐ ๐May 20, 2025 ๐La Pastorale, Geneva
0
10
19
Join us on Day 3 at #ASGBI2025 for the Humanitarian Surgery Symposium and listen to our inspiring speakers from some amazing organisations including: @KidsOperating, @NottFoundation, @OperationHernia, @NIHR_GSU and The Uganda Child Birth Injury Fund. Discover the challenges and
0
4
11
Big news for #EBM! Just out in #BMJ, ROBUST-RCT, pristinely developed, innovative, simple, user-friendly instrument for risk of bias assessment in #RCTs far superior to anything before, will become standard outside of Cochrane and in #Cochrane if they let folks use it.
bmj.com
Recent innovations in evidence based medicine methods, in particular instruments assessing risk of bias in randomised trials, have focused on methodological rigour at the expense of simplicity and...
9
61
161